Economic impact of heart failure with preserved ejection fraction: insights from the ALDO‐DHF trial-Reference-Cited by-同舟云学术

Economic impact of heart failure with preserved ejection fraction: insights from the ALDO‐DHF trial

Published:2020-01-27 Issue:3 Volume:7 Page:786-793
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Hashemi Djawid¹²^ORCID,Dettmann Ludwig³,Trippel Tobias D.¹²,Holzendorf Volker⁴,Petutschnigg Johannes¹²,Wachter Rolf⁵⁶,Hasenfuß Gerd³⁵,Pieske Burkert¹²⁷,Zapf Antonia⁸,Edelmann Frank¹²

Affiliation:

1. Department of Internal Medicine and Cardiology Charité—Universitätsmedizin Berlin, Campus Virchow Klinikum Berlin Germany

2. DZHK (German Centre for Cardiovascular Research), partner site Berlin Berlin Germany

3. Department of Cardiology and Pneumology University of Göttingen Göttingen Germany

4. Clinical Trial Centre University of Leipzig Leipzig Germany

5. DZHK (German Centre for Cardiovascular Research), partner site Göttingen Göttingen Germany

6. Clinic and Policlinic for Cardiology University Hospital Leipzig Leipzig Germany

7. Department of Internal Medicine and Cardiology German Heart Institute Berlin (DHZB) Berlin Germany

8. Institute of Medical Biometry and Epidemiology University Medical Center Hamburg‐Eppendorf (UKE) Hamburg Germany

Funder

German Federal Ministry of Education and Research

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.12606

Reference27 articles.

1. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

2. Burden of Systolic and Diastolic Ventricular Dysfunction in the Community

3. Clinical epidemiology of heart failure

4. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidemiology, Clinical Characteristics and Cause-specific Outcomes in Heart Failure with Preserved Ejection Fraction;Cardiac Failure Review;2023-11-17

2. Sodium tanshinone IIA sulfonate improves adverse ventricular remodeling post MI by reducing myocardial necrosis, modulating inflammation and promoting angiogenesis;Current Pharmaceutical Design;2021-12-24

3. Lipotoxicity: a driver of heart failure with preserved ejection fraction?;Clinical Science;2021-10

4. National Trends in the Burden of Atrial Fibrillation During Hospital Admissions for Heart Failure;Journal of the American Heart Association;2021-06

5. A Practical Risk Score for Prediction of Early Readmission after a First Episode of Acute Heart Failure with Preserved Ejection Fraction;Diagnostics;2021-01-29